| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.16 | 0.3 |